Life Sciences

C.R. Bard receives FDA warning letter

Device Regulation Alert: Safety, Compliance and Reimbursement News, October 20, 2008

The FDA cited C.R. Bard for failing to meet current Good Manufacturing Practices at its Humacao, Puerto Rico–based  facility in a warning letter.

Post a Comment





Please enter your comment below:


Please enter the text below:


Most Popular